ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2477

The Comparison of Childhood Polyarteritis Nodosa and Cutaneous Polyarteritis Nodosa and a New Set of Diagnostic Criteria for Cut-Polyarteritis Nodosa

Erkan Demirkaya1, Seza Ozen1, Turker Turker1, Rubén J. Cuttica2, Paul Brogan1, Pierre Quartier1, Jordi Anton3, Nuray Aktay Ayaz4, Stella Maris Garay5, Graciela Espada1, Raju Khubchandani6, Francesco Zulian1, Arvind Bagga1, Alexandre Belot1, Clovis Artur Silva1, Sulaiman Al-Mayouf1, Amparo Ibanez Estrella1, Sheila Oliveira7, Cengizhan Acikel1, Claudia Saad-Magalhães1, Alberto Martini8 and Nicolino Ruperto1, 1Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy, 2Hospital de Niños Pedro de Elizalde - University of Buenos Aires, Buenes Aires, Argentina, 3Rheumatology, Hospital Sant Joan de Deu, Barcelona, Spain, 4Bakırkoy Maternity and Childrens Education and Research Hospital, Istanbul, Turkey, 5PRINTO, Genoa, Italy, 6Rheumatology, Jaslok Hospital and Research Center, Mumbai, India, 7Istituto Giannina Gaslini, Pediatria II, Reumatologia, Paediatric Rheumatology International Trials Organisation (PRINTO) Coordinating Center, Genoa, Italy, Genova, Italy, 8Pediatric Rheumatology Collaborative Study Group [PRSCG], Cincinnati, OH

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cutaneous manifestations and polyarteritis nodosa

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology: Clinical and Therapeutic Disease III: Childhood Systemic Lupus Erythematosus and Other Vasculidities

Session Type: Abstract Submissions (ACR)

Abstract

Background/Purpose: Systemic polyarteritis nodosa (PAN) is a predominantly medium size vasculitis  characterized by non granulomatous necrotizing vasculitis. We aimed to evaluate clinical, laboratory and imaging features of cutaneous (cut-) PAN and the PAN form  and to develop a new set of diagnostic criteria for cut-PAN in a large international pediatric vasculitis registry available on the PRINTO database.

Methods: We extracted from the PRINTO database all the patients who fulfilled the Ankara 2008-EULAR/PRES/PRINTO criteria for PAN. The cut-PAN patients as per the treating physician diagnosis were also extracted. To define clinical and laboratory characteristics who could help to differentiate cut-PAN  from PAN and univariate logistic regression analysis was performed.

Developing a new set of diagnostic criteria for cut-PAN: Principle component analysis were performed to detect best representative factors of cutaneous symptoms in cut-PAN patients. The one with the highest sensitivity and specificity in the generated models were accepted as diagnostic criteria in our study.

Results: There were 109 and 45 patients classified as PAN, and cut-PAN  respectively with a mean age at diagnosis of 9.47±3.59 years; and 9.12±3.83 years; respectively. The female/male ratio and ethnicity did not differ in the 2 subtypes. The cutaneous group had significantly less constitutional features and less acute phase reactant levels, as expected. The median values (IQR 25-75%) for the ESR and CRP for PAN were 78 (48-108) mm/h and 7.36 (2.76-15.03) mg/dL. Musculoskeletal features such as myalgia was present in 82 (75.2 %) patients with PAN and 18 (40.9%) patients with cut-PAN (p<0.001) both groups. As differentiating features skin infarcts were observed in PAN only and constitutional features, angiographic abnormalities, and organ involvement was not seen in any of the cut-PAN patients. Malaise, fever, severe headache, motor mononeuritis multiplex, sensory peripheral neuropathy, abdominal pain, and hematuria were the most statistically significant clinical characteristics able to differentiate these two entities.

New set of diagnostic criteria for cut-PAN is the absence of any organ involvement (constitutional and musculo skeletal symptoms  are acceptable) and presence of any of 4 cutaneous findings (Livedo reticularis, skin nodules, polymorphous exanthema, panniculitis). Sensitivity of proposed diagnostic criteria obtained from the existing database for cut-PAN  was calculated as 88.8%, specificity  97.8%,  positive  predictive  value 83.3%  and negative  predictive  value  98.6%.  

Conclusion: The large number of patients with other vasculitides and cutaneous PAN has enabled us to have a significant specificity and sensitivity for the suggested criteria. Furhter biological studies are needed to effectively differentiate the two entities.


Disclosure:

E. Demirkaya,
None;

S. Ozen,
None;

T. Turker,
None;

R. J. Cuttica,
None;

P. Brogan,
None;

P. Quartier,
None;

J. Anton,
None;

N. Aktay Ayaz,
None;

S. M. Garay,
None;

G. Espada,
None;

R. Khubchandani,
None;

F. Zulian,
None;

A. Bagga,
None;

A. Belot,
None;

C. A. Silva,
None;

S. Al-Mayouf,
None;

A. Ibanez Estrella,
None;

S. Oliveira,
None;

C. Acikel,
None;

C. Saad-Magalhães,
None;

A. Martini,
None;

N. Ruperto,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-comparison-of-childhood-polyarteritis-nodosa-and-cutaneous-polyarteritis-nodosa-and-a-new-set-of-diagnostic-criteria-for-cut-polyarteritis-nodosa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology